Ready to play
Ready to play
Researchers have developed the first oral treatment for bad cholesterol after years of reliance on injections, providing a more convenient option for patients. The new therapy aims to effectively lower LDL cholesterol levels while reducing the need for long-term injectable interventions. It is expected that this treatment will improve the management of patients with high cholesterol and decrease the risks of cardiovascular and vascular diseases.
Notice: This Is an AI-Generated Summary
Comments (0)